Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2492

Dec 11, 2016

Connecting through the brain

Posted by in categories: biotech/medical, computing, neuroscience

Excellent overview on BMI technology.


Less than a century ago, Hans Berger, a German psychiatrist, was placing silver foil electrodes on his patients’ heads and observing small ripples of continuous electrical voltage emerging from these. These were the first human brain waves to ever be recorded. Since Hans Berger’s first recordings, our knowledge on the brain structure and function has developed considerably. We now have a much clearer understanding of the neuronal sources that generate these electrical signals and the technology that is now available allows us to get a much denser and accurate picture of how these electrical signals change in time and across the human scalp.

The recording and analysis of brain signals has advanced to a level where people are now able to control and interact with devices around them with the use of their brain signals. The field of brain-computer interfaces has in fact garnered huge interest during the past two decades, and the development of low-cost hardware solutions together with the continuously evolving signal analysis techniques, have brought this technology closer to market than ever before.

Continue reading “Connecting through the brain” »

Dec 11, 2016

Tiny barcodes are huge help in personalized cancer therapy

Posted by in categories: biotech/medical, health

In process similar to allergy testing, small quantities of different ‘barcoded’ drugs are tested inside patient’s tumor to determine effectiveness.

Read more

Dec 11, 2016

CellAge: A New Startup Targeting Senescent Cells With Synthetic Biology — Longevity Reporter

Posted by in categories: bioengineering, biotech/medical, life extension

Check out the The Longevity Reporter interview with CellAge as they talk about rejuvenation biotechnology.


Innovative new startup Cell Age is using synthetic biology to develop new ways of targeting and removing senescent cells. We caught up with CEO Mantas Matjusaitis for an interview as their first fundraiser goes live on Lifespan.io (find it here)

Continue reading “CellAge: A New Startup Targeting Senescent Cells With Synthetic Biology — Longevity Reporter” »

Dec 11, 2016

Exercise Improves Arterial Resilience to Age-Related Increases in Oxidative Stress

Posted by in categories: biotech/medical, health, life extension, nanotechnology

Excercise is the best low cost activity you can do as part of your personal longevity strategy. Here we see data showing it can improve resistance to oxidative stress.


Researchers digging deeper into the mechanisms by which exercise produces benefits have found that it improves the resistance of blood vessels to oxidative stress. With age the presence of oxidizing molecules and oxidative modification of proteins, preventing correct function, increases for reasons that include damage to mitochondria, the power plants of the cell. Oxidative damage to molecular machinery is somewhere in the middle of the chain of cause and effect that starts with fundamental forms of damage to cells and tissues and spirals down into age-related diseases. Near all of this oxidation is repaired very quickly, the damaged molecules dismantled and recycled, but in most contexts more of it over the long term is worse than less of it.

Quote:

Continue reading “Exercise Improves Arterial Resilience to Age-Related Increases in Oxidative Stress” »

Dec 10, 2016

‘Cold Caps’ May Halt Breast Cancer Hair Loss

Posted by in category: biotech/medical

This is a big deal to children and adults impacted by cancer and chemo.


Devices reduce blood flow to hair follicles during chemotherapy treatments.

Read more

Dec 10, 2016

Transplanted interneurons can help reduce fear in mice

Posted by in categories: biotech/medical, neuroscience

Wild.


The expression “once bitten, twice shy” is an illustration of how a bad experience can induce fear and caution. How to effectively reduce the memory of aversive events is a fundamental question in neuroscience. Scientists in China are reporting that by transplanting mouse embryonic interneurons into the brains of mice and combining that procedure with training to lessen fear, they can help to reduce the fear response. The study is being published December 8 in Neuron.

“Anxiety and fear-related disorders such as post-traumatic stress disorder [PTSD] cause great suffering and impose high costs to society,” says Yong-Chun Yu, a professor at the Institutes of Brain Science at Fudan University in Shanghai and the study’s senior author. “Pharmacological and behavioral treatments of PTSD can reduce symptoms, but many people tend to relapse. There’s a pressing need for new strategies to treat these refractory cases.”

Continue reading “Transplanted interneurons can help reduce fear in mice” »

Dec 10, 2016

Surprise! An Extra Chromosome May Keep You From Getting Cancer

Posted by in category: biotech/medical

A new study finds that having a single extra chromosome may reduce the chance of cancerous tumors. But like everything, it’s a balancing act.

Read more

Dec 10, 2016

Gene Therapy Prevents Cancer Cells from Surviving in Hypoxic Environment

Posted by in category: biotech/medical

Gene therapy techniques were used to insert a peptide into cultures of human cancer cells that blocked their ability to use the enzyme Hypoxia-inducible factor-1, a heterodimeric transcription factor that enables cell survival under low oxygen conditions by altering the transcription of over 300 genes.

Hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor that acts as the master regulator of cellular response to reduced oxygen levels, thus playing a key role in the adaptation, survival, and progression of tumors. There is significant evidence that inhibition of HIF-1 would be beneficial for cancer therapy, since tumor cells must thrive in a microenvironment characterized by lack of oxygen. In previous work, investigators at the University of Southampton (United Kingdom) discovered a cyclic hexapeptide (cyclo-CLLFVY) that inhibited the HIF-1alpha/HIF-1beta protein–protein interaction in vitro and prevented HIF-1-mediated hypoxia-response signaling in cells. This cyclic peptide was identified by screening a library that contained more than 3.2 million compounds.

With a view to demonstrating the potential for encoding the production of a therapeutic agent in response to a disease marker, the investigators engineered human cells with an additional chromosomal control circuit that conditionally encoded the production of the cyclic peptide HIF-1 inhibitor. They then demonstrated the conditional production of the HIF-1 inhibitor in response to hypoxia, and its inhibitory effect on HIF-1 dimerization and downstream hypoxia-response signaling.

Continue reading “Gene Therapy Prevents Cancer Cells from Surviving in Hypoxic Environment” »

Dec 10, 2016

Engineering cells to regulate glucose

Posted by in categories: bioengineering, biotech/medical

Synthetic Biology Diabetes mellitus affects hundreds of millions of people worldwide. Blood glucose levels are chronically deregulated in diabetics, and this can lead to many serious disorders, including cardiovascular disease and renal failure. Xie et al. engineered a synthetic circuit into human.

Read more

Dec 10, 2016

Scientists track restoration of communication in minimally conscious patient

Posted by in categories: biotech/medical, neuroscience

A severely brain injured woman, who recovered the ability to communicate using her left eye, restored connections and function of the areas of her brain responsible for producing expressive language and responding to human speech, according to new research from Weill Cornell Medicine scientists.

The study, published Dec. 7 in Science Translational Medicine, began 21 months after Margaret Worthen suffered massive strokes, and her continuing recovery was tracked for nearly three years. The research signifies the first time that scientists have captured the restoration of communication of a minimally conscious patient by measuring aspects of brain structure and function before and after communication resumed. It also raises the question of whether other patients in chronic care facilities who appear to be minimally responsive or unresponsive may harbor organized, higher-level brain function.

“From the beginning of Margaret’s attempt to communicate, through the course of our study, we were able to show reorganization of the areas of her brain responsible for expressive language, as well as an exceptionally large change in the correlation across the brain areas in response to human speech,” said study lead author Daniel Thengone, the Fred Plum Fellow in Systems Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. Adds senior study author Dr. Nicholas D. Schiff, the Jerold B. Katz Professor of Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute: “This is a unique demonstration of plastic change in the brain of an adult starting years after a severe brain injury. We showed a convergence of measurements over years and at multiple time points, revealing an evolving biological process of recovery.”

Read more